Alimera Sciences Inc's ability to collect accounts receivable sequentially worsen to 2.81, pointing to a challenging and on top of that deteriorating business climate for the Major Pharmaceutical Preparations industry. Alimera Sciences Inc's Accounts Receivable average collection period in the Jun 30 2024 quarter, has increased to 130 days, from 129 days, in the Mar 31 2024 quarter.

If we take a look into Healthcare sector 506 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2024 from 3227 to 3259.

What is Receivable Turnover Ratio?
What is Alimera Sciences Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ALIM Receivables Turnover Ratio	(Jun 30 2024) II. Quarter	(Mar 31 2024) I. Quarter	(Dec 31 2023) IV. Quarter	(Sep 30 2023) III. Quarter	(Jun 30 2023) II. Quarter
Y / Y Receivable Change	64.15 %	85.67 %	76.14 %	77.32 %	11.17 %
Y / Y Revenue Change	52.92 %	67.27 %	89.98 %	66.25 %	17.18 %
Receivable Turnover Ratio (TTM)	2.81	2.84	2.92	2.85	2.92
ALIM's Total Ranking	# 3259	# 3227	# 1652	# 1652	# 1652
Accounts Receivable average collection period days	130	128	125	128	125
Seq. Receivable Change	8.34 %	-0.93 %	1.77 %	50.26 %	22.55 %
Seq. Revenue Change	15.5 %	-14.99 %	17.9 %	32.1 %	26.33 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 172
Healthcare Sector	# 507
Overall Market	# 3259

Receivable Turnover Ratio Statistics
High	Average	Low
7.94	3.61	2.59
(Dec 31 2014)		(Sep 30 2016)

ALIM Company Profile • Back to ALIM Efficiency Comparisons • Compare ALIM Receivables Turnover Ratio to its Competitors

Financial Statements
Alimera Sciences Inc's Accounts Receivable	$ 37 Millions	Visit ALIM's Balance sheet
Alimera Sciences Inc's Sales TTM	$ 98 Millions	Visit ALIM's Income Statement
Sources of ALIM's Revenues		Visit ALIM's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ALIM's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ALIM's Growth Rates	ALIM's Roa	ALIM's Inventory Turnover Ratio	ALIM's Dividend Comparisons
ALIM's Profitability Ratios	ALIM's Roi	ALIM's Asset Turnover Ratio	ALIM's Dividend Growth
ALIM's Valuation Ratios	ALIM's Roe	ALIM's Financial Strength Ratios	ALIM's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2024, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2024	Receivable at quarter ending Jun 30 2024
Inari Medical Inc	7.27	$ 545.520 Millions	$ 74.992 Millions
Pediatrix Medical Group Inc	7.23	$ 2,002.452 Millions	$ 276.895 Millions
Intelligent Bio Solutions Inc	7.23	$ 3.112 Millions	$ 0.431 Millions
Rhythm Pharmaceuticals Inc	7.20	$ 101.783 Millions	$ 14.127 Millions
Encision Inc	7.18	$ 6.563 Millions	$ 0.914 Millions
Exelixis Inc	7.18	$ 2,013.976 Millions	$ 280.670 Millions
Edwards Lifesciences Corporation	7.16	$ 5,997.400 Millions	$ 837.575 Millions
Journey Medical Corp	7.15	$ 77.681 Millions	$ 10.869 Millions
Tenet Healthcare Corp	7.10	$ 20,916.000 Millions	$ 2,944.000 Millions
Guardant Health Inc	7.10	$ 643.810 Millions	$ 90.666 Millions
Axogen inc	7.10	$ 173.483 Millions	$ 24.444 Millions
Zynex inc	7.09	$ 193.614 Millions	$ 27.290 Millions
Singular Genomics Systems Inc	7.07	$ 2.722 Millions	$ 0.385 Millions
The Oncology Institute Inc	7.03	$ 361.067 Millions	$ 51.328 Millions
Castle Biosciences Inc	7.01	$ 287.589 Millions	$ 40.998 Millions
Intuitive Surgical Inc	6.99	$ 7,571.500 Millions	$ 1,082.475 Millions
Longeveron Inc	6.99	$ 1.229 Millions	$ 0.176 Millions
Alphatec Holdings Inc	6.97	$ 539.497 Millions	$ 77.441 Millions
Voyager Therapeutics Inc	6.95	$ 143.769 Millions	$ 20.672 Millions
Integer Holdings Corporation	6.94	$ 1,666.693 Millions	$ 240.253 Millions
Hca Healthcare Inc	6.93	$ 68,347.000 Millions	$ 9,855.750 Millions
Aurinia Pharmaceuticals Inc	6.93	$ 207.105 Millions	$ 29.867 Millions
Medpace Holdings Inc	6.93	$ 2,030.048 Millions	$ 292.862 Millions
Astrotech Corp	6.91	$ 1.664 Millions	$ 0.241 Millions
Myriad Genetics Inc	6.89	$ 802.200 Millions	$ 116.350 Millions
Merit Medical Systems Inc	6.89	$ 1,299.066 Millions	$ 188.618 Millions
Evolus Inc	6.86	$ 237.260 Millions	$ 34.596 Millions
Skinhealth Systems Inc	6.84	$ 365.260 Millions	$ 53.377 Millions
Pulmonx Corporation	6.84	$ 74.868 Millions	$ 10.950 Millions
3m Company	6.82	$ 30,583.000 Millions	$ 4,481.750 Millions

Date modified: 2026-06-22T14:32:38+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.